Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid Refractory Graft Versus Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01810718
What this trial is testing

Phase I/II for Safety and Efficacy of Nilotinib in a Population Steroid-refractory/or Steroid-dependent cGVHD

Who this might be right for
Chronic Graft Versus Host Disease
Gruppo Italiano Trapianto di Midollo Osseo 22
Testing effectiveness (Phase 2)Study completedNCT02340676
What this trial is testing

A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHD

Who this might be right for
Chronic Graft-versus-host-disease
Dana-Farber Cancer Institute 25
Early research (Phase 1)Study completedNCT03327857
What this trial is testing

Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease

Who this might be right for
Steroid-refractory Acute Graft-versus-Host DiseaseTreatment-refractory Acute Graft-versus-Host Disease
AltruBio Inc. 37
Very early researchLooking for participantsNCT06920199
What this trial is testing

Treatment of Refractory cGVHD by Donor-derived Treg Cell Injection Combined With Recombinant Human Interleukin-2

Who this might be right for
cGVHD
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 18
Large-scale testing (Phase 3)Study completedNCT03112603
What this trial is testing

Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 330
Not applicableAvailableNCT04745637
What this trial is testing

Managed Access Programs for INC424, Ruxolitinib

Who this might be right for
Primary Myelofibrosis (PMF)Post Polycythemia Myelofibrosis (PPV MF)Thrombocythemia Myelofibrosis (PET-MF)+4 more
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT04910152
What this trial is testing

Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD

Who this might be right for
Acute Graft Versus Host DiseaseSteroid Refractory Graft Versus Host Disease
Hannah Choe, MD 2
Not applicableEnded earlyNCT00489216
What this trial is testing

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids

Who this might be right for
Graft Versus Host Disease
UNC Lineberger Comprehensive Cancer Center 2
Large-scale testing (Phase 3)Study completedNCT02913261
What this trial is testing

Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation

Who this might be right for
Corticosteroid Refractory Acute Graft vs Host Disease
Novartis Pharmaceuticals 310
Testing effectiveness (Phase 2)Study completedNCT01954979
What this trial is testing

Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft Versus Host Disease
Beth Israel Deaconess Medical Center 56
Early research (Phase 1)Study completedNCT01596218
What this trial is testing

Brentuximab Vedotin for Steroid Refractory GvHD

Who this might be right for
Graft vs. Host Disease
Massachusetts General Hospital 35
Post-approval studies (Phase 4)Not Yet RecruitingNCT06364319
What this trial is testing

Efficacy and Safety of Anti-CD25 rhMAb in the Treatment of Steroid-Refractory cGVHD

Who this might be right for
cGVHD
Peking University People's Hospital 30
Not applicableEnded earlyNCT04852692
What this trial is testing

Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD Participants

Who this might be right for
Chronic Graft vs Host Disease
Janssen Korea, Ltd., Korea 15
Testing effectiveness (Phase 2)Looking for participantsNCT07364617
What this trial is testing

Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD

Who this might be right for
Graft vs Host Disease
Chang Gung Memorial Hospital 35
Large-scale testing (Phase 3)Ended earlyNCT02524847
What this trial is testing

Methoxsalen and Extracorporeal Photopheresis (ECP) for the Treatment of Pediatric Participants With Steroid Refractory Acute Graft Versus Host Disease

Who this might be right for
Steroid Refractory Acute Graft Versus Host Disease
Therakos, Inc., a Mallinckrodt Company 29
Large-scale testing (Phase 3)Study completedNCT05663827
What this trial is testing

Ruxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host Disease

Who this might be right for
Steroid Refractory GVHD
Yi-Lun Wang 6
Not applicableUnknownNCT05017688
What this trial is testing

Prospective Interventional Study Exploring the Microbiota Recolonization in SR-GvHD Patients Receiving MaaT013

Who this might be right for
Intestinal GVHDSteroid Refractory GVHD
MaaT Pharma 40
Not applicableLooking for participantsNCT07184853
What this trial is testing

Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD

Who this might be right for
Graft vs Host Disease
First Affiliated Hospital of Zhejiang University 122
Testing effectiveness (Phase 2)Looking for participantsNCT07708987
What this trial is testing

Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease.

Who this might be right for
Hematological MalignancyGVHD - Graft-Versus-Host DiseaseSteriod Refractory
Tata Memorial Centre 34
Testing effectiveness (Phase 2)UnknownNCT04971551
What this trial is testing

Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.

Who this might be right for
Acute Graft-Versus-Host Disease
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 60
Next Page